Sign up for email alerts of latest news, events, new funding opportunities and more.
Showing all Discovery Success Stories
14 Jun 2018
MRC-funded researchers at King’s College have shown that rats with spinal cord injuries can re-learn skilled front paw movements after being treated with a gene therapy. The therapy regenerated damaged tissue and could be switched on and off using a common antibiotic.
7 Jun 2018
A study has identified how kidney cancers may develop the ability to spread around the body by hijacking genes from other cell types and ‘stealing’ their functions.
5 Jun 2018
Researchers have shed light on how taking aspirin can help to prevent bowel cancer. They found that the painkiller blocks a key process linked to tumour formation.
30 May 2018
MRC-funded research from Sir Aaron Klug’s lab at MRC LMB underpins a historic gene editing trial.
21 May 2018
New research, funded by the MRC, found that older people with very low heart disease risks also have very little frailty, raising the possibility that frailty could be prevented.
18 May 2018
An international research team funded by the MRC, and led by scientists at the University of Edinburgh and the University of Queensland, has identified three new genes linked to the risk of Alzheimer’s disease.
18 May 2018
Growing levels of resistance to antifungal treatments could lead to increased disease outbreaks and affect food security around the world, according to new research funded by the MRC.
15 May 2018
Scientists have created a new type of genetic replication which demonstrates how the first life on Earth, in the form of RNA, could have replicated itself. The scientists say it utilises a system of genetic replication unlike any known to naturally occur on Earth today.
3 May 2018
MRC scientists have developed a new laboratory test to diagnose peanut allergy. The test has 98% specificity and, unlike current options, it doesn’t run the risk of false-positives or causing allergic reactions.
19 Apr 2018
A new treatment has been shown to significantly improve the speech and word production of stroke patients with aphasia. It uses special software which encourages patients to produce words increasingly quickly.